Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 7/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | PLAU | P00749 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1756430 | 0.89 | EPHX1 (0.77) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| SCHEMBL30434017 | 0.89 | EPHX1 (0.77) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| Ammonia Solution, Strong SCHEMBL28098407 | 0.88 | EPHX1 (0.80) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| Nitrogen SCHEMBL4600490 | 0.87 | EPHX1 (0.74) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| Nitrogen SCHEMBL1785874 | 0.86 | EPHX1 (0.72) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| Nitrogen SCHEMBL8004821 | 0.82 | EPHX1 (0.67) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| SCHEMBL5947431 | 0.80 | MAPT (0.67) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| SCHEMBL11328524 | 0.77 | HDAC1 (0.72) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| Nitrogen SCHEMBL4600884 | 0.76 | MAPT (0.77) | EPHX1HDAC1HDAC8HDAC6MAPT | |
| Nitrogen SCHEMBL10785749 | 0.75 | EPHX1 (0.58) | EPHX1HDAC1HDAC8HDAC6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9127028-B2 | Substrates for chromogenic detection and methods of use in detection assays and kits | VENTANA MEDICAL SYSTEMS, INC. (US) | 2015-09-08 | — | — | US | claimed |
| EP-2606055-B1 | SUBSTRATES FOR CHROMOGENIC DETECTION AND METHODS OF USE IN DETECTION ASSAYS AND KITS | VENTANA MED SYST INC (US) | 2015-06-03 | — | — | EP | claimed |
| EP-2606055-A1 | SUBSTRATES FOR CHROMOGENIC DETECTION AND METHODS OF USE IN DETECTION ASSAYS AND KITS | Ventana Medical Systems, Inc. (US) | 2013-06-26 | — | — | EP | claimed |
| US-20130115593-A1 | SUBSTRATES FOR CHROMOGENIC DETECTION AND METHODS OF USE IN DETECTION ASSAYS AND KITS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-05-09 | — | — | US | claimed |
| EP-2561095-A1 | TWO-COLOR CHROMOGENIC IN SITU HYBRIDIZATION | Ventana Medical Systems, Inc. (US) | 2013-02-27 | — | — | EP | claimed |
| US-20130034853-A1 | TWO-COLOR CHROMOGENIC IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. | 2013-02-07 | — | — | US | claimed |
| WO-2012024185-A1 | SUBSTRATES FOR CHROMOGENIC DETECTION AND METHODS OF USE IN DETECTION ASSAYS AND KITS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2012-02-23 | — | — | WO | claimed |
| WO-2011133625-A1 | TWO-COLOR CHROMOGENIC IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2011-10-27 | — | — | WO | claimed |
| US-11971337-B2 | Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays | VENTANA MEDICAL SYSTEMS, INC. (US) | 2024-04-30 | — | — | US | disclosed |
| US-20220026319-A1 | COMPOSITIONS AND METHODS FOR SIMULTANEOUS INACTIVATION OF ALKALINE PHOSPHATASE AND PEROXIDASE ENZYMES DURING AUTOMATED MULTIPLEX TISSUE STAINING ASSAYS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2022-01-27 | — | — | US | disclosed |
| US-11162877-B2 | Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays | VENTANA MEDICAL SYSTEMS, INC. (US) | 2021-11-02 | — | — | US | disclosed |
| US-20180120202-A1 | COMPOSITIONS AND METHODS FOR SIMULTANEOUS INACTIVATION OF ALKALINE PHOSPHATASE AND PEROXIDASE ENZYMES DURING AUTOMATED MULTIPLEX TISSUE STAINING ASSAYS | VENTANA MEDICAL SYSTEMS, INC. | 2018-05-03 | — | — | US | disclosed |
| EP-3295173-A1 | COMPOSITIONS AND METHODS FOR SIMULTANEOUS INACTIVATION OF ALKALINE PHOSPHATASE AND PEROXIDASE ENZYMES DURING AUTOMATED MULTIPLEX TISSUE STAINING ASSAYS | Ventana Medical Systems, Inc. (US) | 2018-03-21 | — | — | EP | disclosed |
| WO-2016180747-A1 | COMPOSITIONS AND METHODS FOR SIMULTANEOUS INACTIVATION OF ALKALINE PHOSPHATASE AND PEROXIDASE ENZYMES DURING AUTOMATED MULTIPLEX TISSUE STAINING ASSAYS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2016-11-17 | — | — | WO | disclosed |
| EP-2606055-A1 | SUBSTRATES FOR CHROMOGENIC DETECTION AND METHODS OF USE IN DETECTION ASSAYS AND KITS | Ventana Medical Systems, Inc. (US) | 2013-06-26 | — | — | EP | disclosed |
| US-20130115593-A1 | SUBSTRATES FOR CHROMOGENIC DETECTION AND METHODS OF USE IN DETECTION ASSAYS AND KITS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-05-09 | — | — | US | disclosed |
| EP-2561095-A1 | TWO-COLOR CHROMOGENIC IN SITU HYBRIDIZATION | Ventana Medical Systems, Inc. (US) | 2013-02-27 | — | — | EP | disclosed |
| US-20130034853-A1 | TWO-COLOR CHROMOGENIC IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. | 2013-02-07 | — | — | US | disclosed |
| WO-2012024185-A1 | SUBSTRATES FOR CHROMOGENIC DETECTION AND METHODS OF USE IN DETECTION ASSAYS AND KITS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2012-02-23 | — | — | WO | disclosed |
| WO-2011133625-A1 | TWO-COLOR CHROMOGENIC IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2011-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130115593-A1 | SUBSTRATES FOR CHROMOGENIC DETECTION AND METHODS OF USE IN DETECTION ASSAYS AND KITS | ALPG, PYGL, DPYD | EPHX1 722/4885HDAC1 3360/4885HDAC8 2818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.